Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd. Gold
|
Tel: |
027-65317797 15926423062 |
Email: |
422450190@qq.com |
Products Intro: |
Product Name:Urelumab Purity:>95%;1mg/ml Package:200ug;500ug;1mg
|
Company Name: |
ShangHai Biochempartner Co.,Ltd
|
Tel: |
17754423994 17754423994 |
Email: |
2853530910@QQ.com |
Products Intro: |
Product Name:Urelumab CAS:934823-49-1 Purity:95% Package:100ug;500ug;1mg
|
Company Name: |
AntibodySystem
|
Tel: |
17762345272 18162686757 |
Email: |
biolab-reagents@atagenix.com |
Products Intro: |
Product Name:Research Grade Urelumab(DHG11002) CAS:934823-49-1 Purity:PAGE:>95% Package:100ug;1mg
|
|
| Urelumab Basic information |
Product Name: | Urelumab | Synonyms: | Urelumab;Research Grade Urelumab(DHG11002);anti-4-1BB antibody;BMS-663513;Urelumab (anti-TNFRSF9) | CAS: | 934823-49-1 | MF: | | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | Mol File | ![Urelumab Structure]() |
| Urelumab Chemical Properties |
form | Liquid | color | Colorless to light yellow |
| Urelumab Usage And Synthesis |
Biological Activity | Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma. Urelumab is a fully human antibody that targets CD137. The antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with Medarex. | target | 4-1BB |
| Urelumab Preparation Products And Raw materials |
|